Craig Collard was formerly CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, he was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.